Overview
- 20 inspections across 19 sites are on record.
- 15 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2010-09-29.
At a glance
Inspections
20
Sites
19
Observations
15
Career since
Jan 2008
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Fermion OY | 29 Sep 2010 | On file | |
| EirGen Pharma Ltd | 21 Sep 2010 | On file | |
| Zhejiang Cheng Yi Pharmaceutical Co., Ltd | 9 Sep 2010 | On file | |
| Sanofi Winthrop Industrie | 30 Apr 2010 | On file | |
| Sanofi Aventis Recherche & Developpement | 30 Apr 2010 | On file |
Sites inspected
Fermion OYOulu, Finland1 insp.
EirGen Pharma LtdWaterford, Ireland1 insp.
Zhejiang Cheng Yi Pharmaceutical Co., LtdWenzhou, China1 insp.
Sanofi Winthrop IndustrieVitry Sur Seine, France1 insp.
Sanofi Aventis Recherche & DeveloppementVitry Sur Seine, France1 insp.
Co-investigators
Investigators who share inspections with this person.
Michael R Goga2 shared
Donald C Obenhuber2 shared
Barbara D Paul2 shared
Tara R Gooen1 shared
Lloyd D Payne1 shared
Walden H Lee1 shared
Erin D Mccaffery1 shared
Full investigator report
Get the verbatim findings behind Kristy A Zielny's 15 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site